These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 7005620)
1. The use and misuse of androgens. Wilson JD; Griffin JE Metabolism; 1980 Dec; 29(12):1278-95. PubMed ID: 7005620 [TBL] [Abstract][Full Text] [Related]
2. Clinical use of androgens. Snyder PJ Annu Rev Med; 1984; 35():207-17. PubMed ID: 6372655 [TBL] [Abstract][Full Text] [Related]
3. Androgens and erythropoiesis. Shahidi NT N Engl J Med; 1973 Jul; 289(2):72-80. PubMed ID: 4575719 [No Abstract] [Full Text] [Related]
4. [Recent aspects of therapy with androgenic and anabolic steroids]. Schambach H; Nitschke U; Kröhne HJ Z Gesamte Inn Med; 1983 Nov; 38(22):242-6. PubMed ID: 6666179 [TBL] [Abstract][Full Text] [Related]
5. The role of long-acting parenteral testosterone undecanoate compound in the induction of secondary sexual characteristics in males with hypogonadotropic hypogonadism. Giagulli VA; Triggiani V; Carbone MD; Corona G; Tafaro E; Licchelli B; Guastamacchia E J Sex Med; 2011 Dec; 8(12):3471-8. PubMed ID: 21995803 [TBL] [Abstract][Full Text] [Related]
6. Testosterone metabolism and replacement therapy in patients with end-stage renal disease. Johansen KL Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546 [TBL] [Abstract][Full Text] [Related]
7. Safety of estrogen/androgen regimens. Simon JA J Reprod Med; 2001 Mar; 46(3 Suppl):281-90. PubMed ID: 11304876 [TBL] [Abstract][Full Text] [Related]
8. Hormonal therapy of male hypogonadism. Matsumoto AM Endocrinol Metab Clin North Am; 1994 Dec; 23(4):857-75. PubMed ID: 7705324 [TBL] [Abstract][Full Text] [Related]
10. Emerging medication for the treatment of male hypogonadism. Aydogdu A; Swerdloff RS Expert Opin Emerg Drugs; 2016 Sep; 21(3):255-66. PubMed ID: 27552127 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic uses of androgenic agents. Smith GB; Farber M Compr Ther; 1984 Apr; 10(4):11-6. PubMed ID: 6373113 [No Abstract] [Full Text] [Related]
12. Androgens and erythropoiesis: past and present. Shahani S; Braga-Basaria M; Maggio M; Basaria S J Endocrinol Invest; 2009 Sep; 32(8):704-16. PubMed ID: 19494706 [TBL] [Abstract][Full Text] [Related]
13. The onset of a refractory response to androgens in the anemia of bone marrow failure. Gardner FH; Besa EC Trans Am Clin Climatol Assoc; 1977; 88():108-18. PubMed ID: 898530 [TBL] [Abstract][Full Text] [Related]
14. A new testosterone gel (fortesta) for hypogonadism. Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933 [TBL] [Abstract][Full Text] [Related]
15. Androgens and anabolic steroids. Br Med J; 1969 Apr; 2(5650):165-7. PubMed ID: 5778942 [No Abstract] [Full Text] [Related]
16. Current topics in testosterone replacement of hypogonadal men. Nieschlag E Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174 [TBL] [Abstract][Full Text] [Related]
17. Use of androgens in hematologic disease. Fried W Postgrad Med; 1974 May; 55(5):155-61. PubMed ID: 4824723 [No Abstract] [Full Text] [Related]
18. Androgen Misuse and Abuse. Handelsman DJ Endocr Rev; 2021 Jul; 42(4):457-501. PubMed ID: 33484556 [TBL] [Abstract][Full Text] [Related]
19. Testosterone undecanoate in the treatment of male hypogonadism. Edelstein D; Basaria S Expert Opin Pharmacother; 2010 Aug; 11(12):2095-106. PubMed ID: 20642374 [TBL] [Abstract][Full Text] [Related]